Taft attorney Stephen R. Auten was a presenter at the Paragraph IV Disputes Master Symposium on Sept. 30 in Chicago. He co-presented the session titled "Exploring the Use of Reissue Applications to Amend Invalidity Findings in The District Courts."
Auten is head of Taft's Pharmaceutical and Life Sciences Litigation practice area. He is a widely recognized and seasoned attorney in Hatch-Waxman and biosimilar matters, including related patent litigation, and is followed by key industry leaders (brand and generic alike), law firms, analysts, educators and others on his LinkedIn blog "Hatch Waxman ANDA Litigation Forum," which has more than 5,000 members worldwide. He currently represents clients primarily in the areas of Paragraph IV design strategies, Hatch-Waxman litigation and biosimilar market opportunities.